Related Experiment Video
Updated: Aug 8, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
What Should Be Clinicians' Roles in Regulatory Assessment of Prospective Interventions' Risks of Exacerbating
Anushka Bhaskar1, Daniel Carpenter2
1MPhil student in population health sciences at the University of Cambridge in the United Kingdom.
Abstract:
When there is an evidence base that could be used credibly to justify expedited US Food and Drug Administration review, emergency use authorization, or approval, interventions-in-development must be evaluated in terms of their possible downstream influence on public trust and confidence in regulatory processes during a national public health crisis. When regulatory decisions express overconfidence about a prospective intervention's success, there is risk that the costliness of or misinformation about the intervention will exacerbate health inequity. A converse risk is regulators' underestimation of an intervention's value in treating populations at risk for inequitable care. This article considers the nature and scope of clinicians' roles in regulatory processes in which such risks must be considered and balanced to promote public safety and public health.
Insights
Regulatory decisions on new health interventions require balancing speed with public trust, especially during crises. Over or underestimating an intervention
Area of Science:
- Public Health Policy
- Regulatory Science
- Health Equity
Background:
- Expedited review, emergency use authorization, and approval of interventions require assessing downstream impact on public trust during health crises.
- Overconfidence in interventions can worsen health inequity due to cost or misinformation; underestimation risks neglecting populations needing care.
Purpose of the Study:
- To examine the critical role of clinicians in regulatory processes.
- To analyze the balance between promoting public safety and public health.
- To consider the risks of over/underestimation of intervention value in regulatory decision-making.
Main Methods:
- Conceptual analysis of regulatory decision-making frameworks.
- Review of ethical considerations in public health emergencies.
- Discussion of clinician involvement in balancing competing risks.
Main Results:
- Regulatory decisions must account for potential impacts on public trust and confidence.
- The risk of exacerbating health inequity exists with both overconfident and underestimated intervention assessments.
- Clinicians play a vital role in navigating these complex regulatory considerations.
Conclusions:
- Balancing speed, efficacy, and equity in regulatory processes is crucial for public health.
- Understanding and mitigating risks associated with regulatory decisions is essential for maintaining public trust.
- Defining the scope of clinicians' roles in regulatory processes can enhance public safety and health equity.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Ethical Issues
Ethical Concerns in Healthcare:
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Ethical Dilemmas II
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Bias in Epidemiological Studies